Extranodal NK-T-cell lymphoma other diagnostic studies
|
Extranodal NK-T-cell lymphoma Microchapters |
|
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Extranodal NK-T-cell lymphoma other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma other diagnostic studies |
|
FDA on Extranodal NK-T-cell lymphoma other diagnostic studies |
|
CDC on Extranodal NK-T-cell lymphoma other diagnostic studies |
|
Extranodal NK-T-cell lymphoma other diagnostic studies in the news |
|
Blogs on Extranodal NK-T-cell lymphoma other diagnostic studies |
|
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Other diagnostic studies for extranodal NK-T-cell lymphoma include PCR, bone marrow aspiration, bone marrow biopsy, and in situ hybridization.[1][2]
Other Diagnostic Studies
Other diagnostic studies for extranodal NK-T-cell lymphoma include:[1]
-
- High tumor load
- Extensive disease
- Poor response to treatment
- Inferior survival
- Bone marrow aspiration
- Bone marrow biopsy
- In situ hybridization: to detect EBV RNA
References
- ↑ 1.0 1.1 Extranodal NK-/T-cell lymphoma, nasal type. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd530f/. Accessed on February 02, 2016
- ↑ 2.0 2.1 Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2010/627401/. Accessed on February 19, 2016